Neuregulin 1 expression and electrophysiological abnormalities in the Neuregulin 1 transmembrane domain heterozygous mutant mouse

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Long, Leonora E ^a,b,c   Anderson, Paul ^d   Frank, Elisabeth ^a,e   Shaw, Alex ^a,b   Liu, Shijie ^d   Huang, Xu Feng ^a,e   Pinault, Didier ^f   Karl, Tim ^a,b,c   O'Brien, Terence J ^d   Weickert, Cynthia Shannon ^a,b,c   Jones, Nigel C ^d  

^a Schizophrenia Research Institute   (Australia)

^b NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e UNIVERSITY OF WOLLONGONG   (Australia)

^f UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

KETAMINE; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; NEU DIFFERENTIATION FACTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NRG1 PROTEIN, MOUSE;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUDITORY STIMULATION; CONTROLLED STUDY; EXON; FEMALE; FRONTAL CORTEX; GENE EXPRESSION; GENE MUTATION; HETEROZYGOSITY; HIGH FREQUENCY OSCILLATION; HIPPOCAMPUS; MALE; MOUSE; MUTANT; NONHUMAN; NRG1 GENE; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RNA TRANSCRIPTION; SCHIZOPHRENIA; STIMULUS RESPONSE; WILD TYPE; ANIMAL; BRAIN; ELECTROENCEPHALOGRAPHY; GENETICS; HETEROZYGOTE; LOCOMOTION; METABOLISM; MUTANT MOUSE STRAIN; PHOSPHORYLATION; PHYSIOLOGY;

MUS;

ANIMALS; BRAIN; ELECTROENCEPHALOGRAPHY; FEMALE; HETEROZYGOTE; LOCOMOTION; MALE; MICE; MICE, MUTANT STRAINS; NEUREGULIN-1; PHOSPHORYLATION; RECEPTORS, N-METHYL-D-ASPARTATE; RNA, MESSENGER;

EID: 84930681181     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0124114     Document Type: Article

References (82)

1. Stefansson H, Petursson H, Sigurdsson E, Steinthorsdottir V, Bjornsdottir S, Sigmundsson T, et al. Neuregulin 1 and Susceptibility to Schizophrenia. Am J Hum Genet. 2002; 71: 877-892. PMID: 12145742
2. Stefansson H, Sarginson J, Kong A, Yates P, Steinthorsdottir V, Gudfinnsson E, et al. Association of neuregulin 1 with schizophrenia confirmed in a Scottish population. Am J Hum Genet. 2003; 72: 83-87. PMID: 12478479
3. Walss-Bass C, Liu W, Lew DF, Villegas R, Montero P, Dassori A, et al. A novel missense mutation in the transmembrane domain of neuregulin 1 is associated with schizophrenia. Biol Psychiatry. 2006; 60: 548-553. PMID: 16730337
4. Williams NM, Preece A, Spurlock G, Norton N, Williams HJ, Zammit S, et al. Support for genetic variation in neuregulin 1 and susceptibility to schizophrenia. Mol Psychiatry. 2003; 8: 485-487. PMID: 12808428
5. Zhao X, Shi Y, Tang J, Tang R, Yu L, Gu N, et al. A case control and family based association study of the neuregulin 1 gene and schizophrenia. Journal of Medical Genetics. 2004; 41: 31-34. PMID: 14729827
6. Chong VZ, Thompson M, Beltaifa S, Webster MJ, Law AJ, Weickert CS. Elevated neuregulin-1 and ErbB4 protein in the prefrontal cortex of schizophrenic patients. Schizophr Res. 2008; 100: 270-280. doi: 10.1016/j.schres.2007.12.474 PMID: 18243664
7. Law AJ, Lipska BK, Weickert CS, Hyde TM, Straub RE, Hashimoto R, et al. Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5′ SNPs associated with the disease. Proc Natl Acad Sci U S A. 2006; 103: 6747-6752. PMID: 16618933
8. Hashimoto R, Straub RE, Weickert CS, Hyde TM, Kleinman JE, Weinberger DR. Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia. Mol Psychiatry. 2004; 9: 299-307. PMID: 14569272
9. Weickert CS, Tiwari Y, Schofield PR, Mowry BJ, Fullerton JM. Schizophrenia-associated HapICE haplotype is associated with increased NRG1 type III expression and high nucleotide diversity. Transl Psychiatry. 2012; 2: e104. doi: 10.1038/tp.2012.25 PMID: 22832904
10. Karl T, Duffy L, Scimone A, Harvey RP, Schofield PR. Altered motor activity, exploration and anxiety in heterozygous neuregulin 1 mutant mice: implications for understanding schizophrenia. Genes Brain Behav. 2007; 6: 677-687. PMID: 17309661
11. Holmes WE, Sliwkowski MX, Akita RW, Henzel WJ, Lee J, Park JW, et al. Identification of heregulin, a specific activator of p185erbB2. Science. 1992; 256: 1205-1210. PMID: 1350381
12. Peles E, Bacus SS, Koski RA, Lu HS, Wen D, Ogden SG, et al. Isolation of the NeuHER-2 stimulatory ligand: A 44 kd glycoprotein that induces differentiation of mammary tumor cells. Cell. 1992; 69: 205-216. PMID: 1348215
13. Marchionni MA, Goodearl AD, Chen MS, Bermingham-McDonogh O, Kirk C, Hendricks M, et al. Glial growth factors are alternatively spliced erbB2 ligands expressed in the nervous system. Nature. 1993; 362: 312-318. PMID: 8096067
14. Meyer D, Yamaai T, Garratt A, Riethmacher-Sonnenberg E, Kane D, Theill LE, et al. Isoform-specific expression and function of neuregulin. Development. 1997; 124: 3575-3586. PMID: 9342050
15. Falls DL, Rosen KM, Corfas G, Lane WS, Fischbach GD. ARIA, a protein that stimulates acetylcholine receptor synthesis, is a member of the neu ligand family. Cell. 1993; 72: 801-815. PMID: 8453670
16. Burgess TL, Ross SL, Qian YX, Brankow D, Hu S. Biosynthetic processing of neu differentiation factor. Glycosylation trafficking, and regulated cleavage from the cell surface. J Biol Chem. 1995; 270: 19188-19196. PMID: 7642587
17. Hu X, Hicks CW, He W, Wong P, Macklin WB, Trapp BD, et al. Bace1 modulates myelination in the central and peripheral nervous system. Nat Neurosci. 2006; 9: 1520-1525. PMID: 17099708
18. Willem M, Garratt AN, Novak B, Citron M, Kaufmann S, Rittger A, et al. Control of peripheral nerve myelination by the β-secretase BACE1. Science. 2006; 314: 664-666. PMID: 16990514
19. Montero JC, Rodriguez-Barrueco R, Yuste L, Juanes PP, Borges J, Esparis-Ogando A, et al. The extracellular linker of pro-neuregulin-alpha2c is required for efficient sorting and juxtacrine function. Mol Biol Cell. 2007; 18: 380-393. PMID: 17108327
20. Loeb JA, Susanto ET, Fischbach GD. The neuregulin precursor proARIA is processed to ARIA after expression on the cell surface by a protein kinase C-enhanced mechanism. Mol Cell Neurosci. 1998; 11: 77-91. PMID: 9608535
21. Loeb JA, Fischbach GD. ARIA can be released from extracellular matrix through cleavage of a heparin-binding domain. J Cell Biol. 1995; 130: 127-135. PMID: 7540614
22. Tamura H, Kawata M, Hamaguchi S, Ishikawa Y, Shiosaka S. Processing of neuregulin-1 by neuropsin regulates GABAergic neuron to control neural plasticity of the mouse hippocampus. J Neurosci. 2012; 32: 12657-12672. doi: 10.1523/JNEUROSCI.2542-12.2012 PMID: 22972991
23. Yokozeki T, Wakatsuki S, Hatsuzawa K, Black RA, Wada I, Sehara-Fujisawa A. Meltrin beta (ADAM19) mediates ectodomain shedding of Neuregulin beta1 in the Golgi apparatus: fluorescence correlation spectroscopic observation of the dynamics of ectodomain shedding in living cells. Genes Cells. 2007; 12: 329-343. PMID: 17352738
24. O'Tuathaigh CMP, Babovic D, O'Sullivan GJ, Clifford JJ, Tighe O, Croke DT, et al. Phenotypic characterization of spatial cognition and social behavior in mice with 'knockout' of the schizophrenia risk gene neuregulin 1. Neuroscience. 2007; 147: 18-27. PMID: 17512671
25. Duffy L, Cappas E, Lai D, Boucher AA, Karl T. Cognition in transmembrane domain neuregulin 1 mutant mice. Neuroscience. 2010; 170: 800-807. doi: 10.1016/j.neuroscience.2010.07.042 PMID: 20678553
26. Chesworth R, Downey L, Logge W, Killcross S, Karl T. Cognition in female transmembrane domain neuregulin 1 mutant mice. Behav Brain Res. 2012; 226: 218-223. doi: 10.1016/j.bbr.2011.09.019 PMID: 21944941
27. Karl T, Burne THJ, Van den Buuse M, Chesworth R. Do transmembrane domain neuregulin 1 mutant mice exhibit a reliable sensorimotor gating deficit? Behav Brain Res. 2011; 223: 336-341. doi: 10.1016/j.bbr.2011.04.051 PMID: 21605597
28. Boucher AA, Arnold JC, Duffy L, Schofield PR, Micheau J, Karl T. Heterozygous neuregulin 1 mice are more sensitive to the behavioural effects of Delta9-tetrahydrocannabinol. Psychopharmacology. 2007; 192: 325-336. PMID: 17333138
29. Boucher AA, Hunt GE, Karl T, Micheau J, McGregor IS, Arnold JC. Heterozygous neuregulin 1 mice display greater baseline and Delta(9)-tetrahydrocannabinol-induced c-Fos expression. Neuroscience. 2007; 149: 861-870. PMID: 17905522
30. Boucher AA, Hunt GE, Micheau J, Huang X-F, McGregor IS, Karl T, et al. The schizophrenia susceptibility gene neuregulin 1 modulates tolerance to the effects of cannabinoids. Int J Neuropsychopharmacol. 2011; 14: 631-643. doi: 10.1017/S146114571000091X PMID: 20701826
31. Long LE, Chesworth R, Arnold JC, Karl T. A follow-up study: acute behavioural effects of Δ9-THC in female heterozygous Neuregulin 1 transmembrane domain mutant mice. Psychopharmacology. 2010; 211: 277-289. doi: 10.1007/s00213-010-1896-6 PMID: 20571781
32. Long LE, Chesworth R, Huang X-F, McGregor IS, Arnold JC, Karl T. Transmembrane domain Nrg1 mutant mice show altered susceptibility to the neurobehavioural actions of repeated THC exposure in adolescence. Int J Neuropsychopharmacol. 2013; 16: 163-175. doi: 10.1017/S1461145711001854 PMID: 22226049
33. Long LE, Chesworth R, Huang X-F, Wong A, Spiro A, McGregor IS, et al. Distinct neurobehavioural effects of cannabidiol in transmembrane domain neuregulin 1 mutant mice. PLoS One. 2012; 7: e34129. doi: 10.1371/journal.pone.0034129 PMID: 22509273
34. Spencer JR, Darbyshire KM, Boucher AA, Kashem MA, Long LE, McGregor IS, et al. Novel molecular changes induced by Nrg1 hypomorphism and Nrg1-cannabinoid interaction in adolescence: a hippocampal proteomic study in mice. Front Cell Neurosci. 2013; 7: 15. doi: 10.3389/fncel.2013.00015 PMID: 23447498
35. Karl T, Arnold JC. What does a mouse tell us about neuregulin 1-cannabis interactions? Front Cell Neurosci. 2013; 7: 18. doi: 10.3389/fncel.2013.00018 PMID: 23447438
36. Uhlhaas PJ, Singer W. Abnormal neural oscillations and synchrony in schizophrenia. Nat Rev Neurosci. 2010; 11: 100-113. doi: 10.1038/nrn2774 PMID: 20087360
37. Fries P, Reynolds JH, Rorie AE, Desimone R. Modulation of oscillatory neuronal synchronization by selective visual attention. Science. 2001; 291: 1560-1563. PMID: 11222864
38. Tallon-Baudry C, Bertrand O. Oscillatory gamma activity in humans and its role in object representation. Trends Cog Sci. 1999; 3: 151-162.
39. Melloni L, Molina C, Pena M, Torres D, Singer W, Rodriguez E. Synchronization of Neural Activity across Cortical Areas Correlates with Conscious Perception. J Neurosci. 2007; 27: 2858-2865. PMID: 17360907
40. Elvevag B, Goldberg TE. Cognitive impairment in schizophrenia is the core of the disorder. Crit Rev Neurobiol. 2000; 14: 1-21. PMID: 11253953
41. Fazzari P, Paternain AV, Valiente M, Pla R, Lujan R, Lloyd K, et al. Control of cortical GABA circuitry development by Nrg1 and ErbB4 signalling. Nature. 2010; 464: 1376-1380. doi: 10.1038/nature08928 PMID: 20393464
42. Freund TF. Interneuron Diversity series: Rhythm and mood in perisomatic inhibition. Trends Neurosci. 2003; 26: 489-495. PMID: 12948660
43. Curley AA, Lewis DA. Cortical basket cell dysfunction in schizophrenia. J Physiol. 2012; 590: 715-724. doi: 10.1113/jphysiol.2011.224659 PMID: 22219337
44. Hashimoto T, Arion D, Unger T, Maldonado-Aviles JG, Morris HM, Volk DW, et al. Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia. Mol Psychiatry. 2008; 13: 147-161. PMID: 17471287
45. Hashimoto T, Volk DW, Eggan SM, Mirnics K, Pierri JN, Sun Z, et al. Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J Neurosci. 2003; 23: 6315-6326. PMID: 12867516
46. Woo TU, Spencer K, McCarley RW. Gamma oscillation deficits and the onset and early progression of schizophrenia. Harv Rev Psychiatry. 2010; 18: 173-189. doi: 10.3109/10673221003747609 PMID: 20415633
47. Bitanihirwe BK, Lim MP, Kelley JF, Kaneko T, Woo TU. Glutamatergic deficits and parvalbumin-containing inhibitory neurons in the prefrontal cortex in schizophrenia. BMC Psychiatry. 2009; 9: 71. doi: 10.1186/1471-244X-9-71 PMID: 19917116
48. Wang CZ, Yang SF, Xia Y, Johnson KM. Postnatal phencyclidine administration selectively reduces adult cortical parvalbumin-containing interneurons. Neuropsychopharmacology. 2008; 33: 2442-2455. PMID: 18059437
49. Gonzalez-Burgos G, Lewis DA. NMDA receptor hypofunction, parvalbumin-positive neurons, and cortical gamma oscillations in schizophrenia. Schizophr Bull. 2012; 38: 950-957. doi: 10.1093/schbul/sbs010 PMID: 22355184
50. Vullhorst D, Neddens J, Karavanova I, Tricoire L, Petralia RS, McBain CJ, et al. Selective expression of ErbB4 in interneurons, but not pyramidal cells, of the rodent hippocampus. J Neurosci. 2009; 29: 12255-12264. doi: 10.1523/JNEUROSCI.2454-09.2009 PMID: 19793984
51. Woo R-S, Li X-M, Tao Y, Carpenter-Hyland E, Huang YZ, Weber J, et al. Neuregulin-1 Enhances Depolarization-Induced GABA Release. Neuron. 2007; 54: 599-610. PMID: 17521572
52. Li KX, Lu YM, Xu ZH, Zhang J, Zhu JM, Zhang JM, et al. Neuregulin 1 regulates excitability of fast-spiking neurons through Kv1.1 and acts in epilepsy. Nat Neurosci. 2012; 15: 267-273. doi: 10.1038/nn.3006 PMID: 22158511
53. Li B, Woo R-S, Mei L, Malinow R. The Neuregulin-1 Receptor ErbB4 Controls Glutamatergic Synapse Maturation and Plasticity. Neuron. 2007; 54: 583-597. PMID: 17521571
54. Garcia RA, Vasudevan K, Buonanno A. The neuregulin receptor ErbB-4 interacts with PDZ-containing proteins at neuronal synapses. Proc Natl Acad Sci U S A. 2000; 97: 3596-3601. PMID: 10725395
55. Huang YZ, Won S, Ali DW, Wang Q, Tanowitz M, Du QS, et al. Regulation of neuregulin signaling by PSD-95 interacting with ErbB4 at CNS synapses. Neuron. 2000; 26: 443-455. PMID: 10839362
56. Bjarnadottir M, Misner DL, Haverfield-Gross S, Bruun S, Helgason VG, Stefansson H, et al. Neuregulin1 (NRG1) signaling through Fyn modulates NMDA receptor phosphorylation: differential synaptic function in NRG1+/- knock-outs compared with wild-type mice. J Neurosci. 2007; 27: 4519-4529. PMID: 17460065
57. Del Pino I, Garcia-Frigola C, Dehorter N, Brotons-Mas JR, Alvarez-Salvado E, Martinez de Lagran M, et al. Erbb4 deletion from fast-spiking interneurons causes schizophrenia-like phenotypes. Neuron. 2013; 79: 1152-1168. doi: 10.1016/j.neuron.2013.07.010 PMID: 24050403
58. Fisahn A, Neddens J, Yan L, Buonanno A. Neuregulin-1 modulates hippocampal gamma oscillations: implications for schizophrenia. Cereb Cortex. 2009; 19: 612-618. doi: 10.1093/cercor/bhn107 PMID: 18632742
59. Huang X, Miller W. A time-efficient, linear-space local similarity algorithm. Adv Appl Math. 1991; 12: 337-357.
60. Dillman AA, Hauser DN, Gibbs JR, Nalls MA, McCoy MK, Rudenko IN, et al. mRNA expression, splicing and editing in the embryonic and adult mouse cerebral cortex. Nat Neurosci. 2013; 16: 499-506. doi: 10.1038/nn.3332 PMID: 23416452
61. Agarwal A, Zhang M, Trembak-Duff I, Unterbarnscheidt T, Radyushkin K, Dibaj P, et al. Dysregulated expression of neuregulin-1 by cortical pyramidal neurons disrupts synaptic plasticity. Cell Rep. 2014; 8: 1130-1145. doi: 10.1016/j.celrep.2014.07.026 PMID: 25131210
62. Hakami T, Jones NC, Tolmacheva EA, Gaudias J, Chaumont J, Salzberg M, et al. NMDA receptor hypofunction leads to generalized and persistent aberrant gamma oscillations independent of hyperlocomotion and the state of consciousness. PLoS One. 2009; 4: e6755. doi: 10.1371/journal.pone.0006755 PMID: 19707548
63. Delorme A, Makeig S. EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysis. J Neurosci Methods. 2004; 134: 9-21. PMID: 15102499
64. Jones NC, Martin S, Megatia I, Hakami T, Salzberg MR, Pinault D, et al. A genetic epilepsy rat model displays endophenotypes of psychosis. Neurobiol Dis. 2010; 39: 116-125. doi: 10.1016/j.nbd.2010.02.001 PMID: 20153428
65. Liu X, Bates R, Yin D-M, Shen C, Wang F, Su N, et al. Specific regulation of NRG1 isoform expression by neuronal activity. J Neurosci. 2011; 31: 8491-8501. doi: 10.1523/JNEUROSCI.5317-10.2011 PMID: 21653853
66. Wang JY, Miller SJ, Falls DL. The N-terminal Region of Neuregulin Isoforms Determines the Accumulation of Cell Surface and Released Neuregulin Ectodomain. J Biol Chem. 2001; 276: 2841-2851. PMID: 11042203
67. Colantuoni C, Lipska BK, Ye T, Hyde TM, Tao R, Leek JT, et al. Temporal dynamics and genetic control of transcription in the human prefrontal cortex. Nature. 2011; 478: 519-523. doi: 10.1038/nature10524 PMID: 22031444
68. Harris L, Lockstone H, Khaitovich P, Shannon Weickert C, Webster M, Bahn S. Gene expression in the prefrontal cortex during adolescence: implications for the onset of schizophrenia. BMC Med Genomics. 2009; 2: 28. doi: 10.1186/1755-8794-2-28 PMID: 19457239
69. Bao J, Wolpowitz D, Role LW, Talmage DA. Back signaling by the Nrg-1 intracellular domain. J Cell Biol. 2003; 161: 1133-1141. PMID: 12821646
70. Kulikova SP, Tolmacheva EA, Anderson P, Gaudias J, Adams BE, Zheng T, et al. Opposite effects of ketamine and deep brain stimulation on rat thalamocortical information processing. Eur J Neurosci. 2012; 36: 3407-3419. doi: 10.1111/j.1460-9568.2012.08263.x PMID: 22928838
71. Saunders JA, Gandal MJ, Siegel SJ. NMDA antagonists recreate signal-to-noise ratio and timing perturbations present in schizophrenia. Neurobiol Dis. 2012; 46: 93-100. doi: 10.1016/j.nbd.2011.12.049 PMID: 22245663
72. Spencer KM. Baseline gamma power during auditory steady-state stimulation in schizophrenia. Front Hum Neurosci. 2011; 5: 190. doi: 10.3389/fnhum.2011.00190 PMID: 22319485
73. Flames N, Long JE, Garratt AN, Fischer TM, Gassmann M, Birchmeier C, et al. Short- and long-range attraction of cortical GABAergic interneurons by neuregulin-1. Neuron. 2004; 44: 251-261. PMID: 15473965
74. Andersson RH, Johnston A, Herman PA, Winzer-Serhan UH, Karavanova I, Vullhorst D, et al. Neuregulin and dopamine modulation of hippocampal gamma oscillations is dependent on dopamine D4 receptors. Proc Natl Acad Sci U S A. 2012; 109: 13118-13123. doi: 10.1073/pnas.1201011109 PMID: 22822214
75. Barz CS, Bessaih T, Abel T, Feldmeyer D, Contreras D. Sensory encoding in Neuregulin 1 mutants. Brain Struct Fuct. 2014.
76. Deakin IH, Nissen W, Law AJ, Lane T, Kanso R, Schwab MH, et al. Transgenic overexpression of the type I isoform of neuregulin 1 affects working memory and hippocampal oscillations but not long-term potentiation. Cereb Cortex. 2012; 22: 1520-1529. doi: 10.1093/cercor/bhr223 PMID: 21878485
77. Nakazawa T, Komai S, Tezuka T, Hisatsune C, Umemori H, Semba K, et al. Characterization of Fyn-mediated tyrosine phosphorylation sites on GluR epsilon 2 (NR2B) subunit of the N-methyl-D-aspartate receptor. J Biol Chem. 2001; 276: 693-699. PMID: 11024032
78. Prybylowski K, Chang K, Sans N, Kan L, Vicini S, Wenthold RJ. The synaptic localization of NR2B-containing NMDA receptors is controlled by interactions with PDZ proteins and AP-2. Neuron. 2005; 47: 845-857. PMID: 16157279
79. Howard MW, Rizzuto DS, Caplan JB, Madsen JR, Lisman J, Aschenbrenner-Scheibe R, et al. Gamma oscillations correlate with working memory load in humans. Cereb Cortex. 2003; 13: 1369-1374. PMID: 14615302
80. Yamamoto J, Suh J, Takeuchi D, Tonegawa S. Successful execution of working memory linked to synchronized high-frequency gamma oscillations. Cell. 2014; 157: 845-857. doi: 10.1016/j.cell.2014.04.009 PMID: 24768692
81. van den Buuse M, Wischhof L, Lee RX, Martin S, Karl T. Neuregulin 1 hypomorphic mutant mice: enhanced baseline locomotor activity but normal psychotropic drug-induced hyperlocomotion and prepulse inhibition regulation. Int J Neuropsychopharmacol. 2009; 12: 1383-1393. doi: 10.1017/S1461145709000388 PMID: 19400983
82. Luo X, He W, Hu X, Yan R. Reversible overexpression of bace1-cleaved neuregulin-1 N-terminal fragment induces schizophrenia-like phenotypes in mice. Biol Psychiatry. 2014; 76: 120-127. doi: 10.1016/j.biopsych.2013.09.026 PMID: 24210810